https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Approval-of-LinzessTablets-025-mg-in-Japan-for-Additional-Indication-of-Chronic-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- August 21, 2018